Health Condition 1: L811- Chloasma Health Condition 2: L81- Other disorders of pigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of all genders, belonging to 18 to 60 years age group and willing to participate in the trial voluntarily Clinically diagnosed patients of epidermal melasma using Woodâ??s lamp examination (340-400 nm) Patients willing to sign the informed consent form
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Female patient using oral contraceptives and hormonal intrauterine devices. Patients treated with tretinoin through the last 3 weeks Patients treated with hydroquinone through the last 6 months before entering the study Patients who have used any other bleaching creams or topical steroid creams for at least 4 weeks before entering the study Patients who undergone any laser therapies and chemical peeling Having used or consuming photosensitizing substances in past 4 weeks Patients with drug or alcohol addiction Patient having any endocrine or auto-immune disease Patients with Diabetes mellitus, renal insufficiency, severe liver, spleen, or heart diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MASI Index, Melasma QoL Index, PGATimepoint: 2 weeks, 4 weeks, 6 weeks, 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| CBC, LFT, KFT, Urine (R/M)Timepoint: 0 day, 14th day, 56th day | — |
Countries
India
Contacts
Jamia Hamdard